Successful treatment with imatinib combined with less intensive chemotherapy (vincristine and dexamethasone) as induction therapy in a very elderly patient with Philadelphia chromosome-positive acute lymphoblastic leukemia

Int J Hematol. 2007 Apr;85(3):273-4. doi: 10.1532/IJH97.06216.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Benzamides
  • Dexamethasone / administration & dosage
  • Female
  • Genes, abl / drug effects*
  • Humans
  • Imatinib Mesylate
  • Philadelphia Chromosome*
  • Piperazines / administration & dosage
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Pyrimidines / administration & dosage
  • Remission Induction / methods
  • Vincristine / administration & dosage

Substances

  • Benzamides
  • Piperazines
  • Pyrimidines
  • Vincristine
  • Dexamethasone
  • Imatinib Mesylate